Gene · 4921
Papers2,653
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,653
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hepatocyte-hepatic stellate cell interactions in liver fibrosis: Mechanisms and therapeutic implications. | Hepatol Commun | 2026 | 41564388 | PubTator, text mining | PubMed |
| Single-cell and immune-context integration identifies basement-membrane/metastasis signatures that sharpen bladder-cancer diagnosis and prognosis. | Discov Oncol | 2026 | 41533176 | PubTator, text mining | PubMed |
| Decoding collagen cues: the interplay of integrins and discoidin domain receptors in health and disease. | J Biomed Sci | 2026 | 41492134 | PubTator, text mining | PubMed |
| Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2‑associated sensitivity in ACHN models. | Korean J Physiol Pharmacol | 2026 | 41324163 | PubTator, text mining | PubMed |
| Identification and In Silico Characterization of an Alternatively Spliced Novel Transcript of Human DDR2 Gene. | Cell Biochem Biophys | 2026 | 41175169 | PubTator, text mining | PubMed |
| Investigating the Mechanisms of Pazopanib-induced Hepatotoxicity: Insights from Network Toxicology, Microarray Analysis, and Machine Learning. | Curr Med Chem | 2026 | 40417760 | PubTator, text mining | PubMed |
| Regulation of Cancer Stem Cells in the Tumor Microenvironment. | Cancer Heterog Plast | 2025 | 41868064 | PubTator, text mining | PubMed |
| A Novel Mutation in DDR2 Associated with Warburg-Cinotti Syndrome in a Neonate. | Arch Iran Med | 2025 | 41778429 | PubTator, text mining | PubMed |
| Genetic and transcriptomic analyses of early-onset colon cancer (EOCC): a post hoc analysis of 2973 patients from two adjuvant randomized trials. | ESMO Gastrointest Oncol | 2025 | 41646486 | PubTator, text mining | PubMed |
| Genomic Profiling of Highly Aggressive Musculoskeletal Sarcomas Identifies Potential Therapeutic Targets: A Single-Center Experience. | Cancers (Basel) | 2025 | 41514647 | PubTator, text mining | PubMed |
| Molecular-Level Design Principles and Strategies of Peptide Self-Assembly Nanomaterials: From Sequence Engineering to Functional Applications. | Int J Nanomedicine | 2025 | 41438428 | PubTator, text mining | PubMed |
| Bioinformatics Analysis of Hypoxia-Related Mechanisms in Endometriosis: DDR2 as a Potential Diagnostic and Therapeutic Biomarker. | Biomed Res Int | 2025 | 41424583 | PubTator, text mining | PubMed |
| Nationwide comprehensive genomic profiling defines the genomic landscape of hepatocellular carcinoma across etiologies. | Sci Rep | 2025 | 41331082 | PubTator, text mining | PubMed |
| Frontiers in mechanobiology and mechanomedicine. | Med X | 2025 | 41323575 | PubTator, text mining | PubMed |
| Cellular Selectivity Analyses Reveal Distinguishing Profiles for Type II Kinase Inhibitors. | bioRxiv | 2025 | 41278810 | PubTator, text mining | PubMed |
| Transmembrane association of DDR1 and DDR2 mediated by Leucine zipper motifs. | Magn Reson Lett | 2025 | 41278260 | PubTator, text mining | PubMed |
| Warburg-Cinotti disease variant p.Tyr740Cys enhances catalytic activity of DDR2 kinase. | PLoS One | 2025 | 41259339 | PubTator, text mining | PubMed |
| PI3K/mTORC2-RICTOR axis in early squamous non-small-cell lung cancer: genomics, molecular expression, and clinical relevance. | Ther Adv Med Oncol | 2025 | 41221490 | PubTator, text mining | PubMed |
| Collagen Signaling via DDR1 Exacerbates Barriers to Macromolecular Drug Delivery in a 3D Model of Pancreatic Cancer Fibrosis. | Small | 2025 | 41170605 | PubTator, text mining | PubMed |
| Integration of machine learning to reveal the correlation between ferroptosis and M2 macrophages in head and neck squamous cell carcinoma. | Discov Oncol | 2025 | 41085826 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4921/papers?page=3